Top Story

Preemptive DAA therapy improves outcomes of negative-to-positive HCV heart transplant

November 16, 2018
Meeting NewsVideo

VIDEO: Opioid use pre vs. post liver transplant largely remains steady

November 15, 2018
SAN FRANCISCO — In this exclusive video perspective from The Liver Meeting 2018, Monica Konerman, MD, director of the Michigan Medicine NAFLD Clinic, discusses…
Meeting News

Scoring methods inaccurately predict who will relapse to alcohol post LT

November 15, 2018
SAN FRANCISCO — Current methods for predicting harmful alcohol relapse after liver transplantation accurately predict who will not relapse but have low positive…
Meeting News

Alcohol relapse score predicts early liver transplant eligibility

November 12, 2018
SAN FRANCISCO — A novel prognostic score using four objective pretransplant variables identified patients with alcoholic hepatitis who were candidates for early…
More Headlines »

Cirrhosis and Hepatic Encephalopathy – Managing Their Consequences and Complications

This activity is supported by an educational grant from Salix Pharmaceuticals, a division of Valeant Pharmaceuticals North America LLC.

Cirrhosis, or advanced fibrosis of the liver, can lead to serious health sequelae or death. However, substantial…
More »
GI Bookshelf

Question 28: I Have A Patient With Biliary-Type Pain, But No Other Evidence Of Bile Duct Disease (Normal Diameter Duct On Ultrasound, Normal Liver Function Tests). How Should Such A Patient Be Managed?

From Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition
More »
Meeting News

Expert reviews clinical liver disease take-aways from DDW 2018

June 5, 2018
More »